This inventor holds 1 USPTO granted patent. Top assignee: Sutro Biopharma, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Miao Wen: Innovator in Antibody Research
Introduction
Miao Wen is a notable inventor recognized for his contributions to the field of biopharmaceuticals. He has made significant strides in developing innovative solutions that address critical medical challenges. His work primarily focuses on anti-tissue factor antibodies and their applications.
Latest Patents
Miao Wen holds a patent for "ANTI-TISSUE FACTOR ANTIBODIES AND ANTIBODY CONJUGATES, COMPOSITIONS COMPRISING ANTI-TISSUE FACTOR ANTIBODIES OR ANTIBODY CONJUGATES, AND METHODS OF MAKING AND USING ANTI-TISSUE FACTOR ANTIBODIES AND ANTIBODY CONJUGATES." This patent highlights his expertise in creating advanced therapeutic agents that can potentially improve patient outcomes.
Career Highlights
Miao Wen is currently employed at Sutro Biopharma, Inc., where he continues to push the boundaries of antibody research. His work at the company has been instrumental in developing novel treatments that leverage the power of antibodies to combat various diseases.
Collaborations
Throughout his career, Miao has collaborated with talented individuals such as Daniel Calarese and Grace Jungeun Lee. These partnerships have fostered a collaborative environment that enhances innovation and accelerates research progress.
Conclusion
Miao Wen's contributions to the field of biopharmaceuticals, particularly in antibody research, underscore his role as a leading inventor. His patent and ongoing work at Sutro Biopharma, Inc. reflect his commitment to advancing medical science and improving therapeutic options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile